**UNITED
      STATES**


**SECURITIES
      AND EXCHANGE COMMISSION**


**Washington,
      D.C. 20549**





**FORM
      10-QSB/A**





(Amendment
      No. 1)





(Mark
      One)


x
            QUARTERLY
                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
                1934





**For
      the quarterly period ended March 31, 2007**




o
            TRANSITION
                REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE
                ACT




For
      the
      transition period from ______ to __________





*Commission
      File Number* : 0-27569





**NATURAL
      NUTRITION, INC.**


(Exact
      name of small business issuer as specified in its charter)





**Nevada**
            
            **65-0847995**(State
                or other jurisdiction of incorporation or organization)
            
            (IRS
                Employer Identification No.)**109
                North Post Oak Lane, Suite 422****Houston,
                TX 77024**(Address
                of principal executive offices)**(713)
                621-2737**(Issuer's
                telephone number)**(Formerly
                CSI Business Finance,
                Inc.)**





Check
      whether the issuer (1) filed all reports required to be filed by Section 13
      or
      15(d) of the Exchange Act during the past 12 months (or for such shorter period
      that the registrant was required to file such reports), and (2) has been subject
      to such filing requirements for the past 90 days. oYes  x
      No





Indicate
      by check whether the registrant is a shell company (as defined in Rule 12b-2
      of
      the Exchange Act). Yes o
      No x





The
      number of shares outstanding of our common stock at April 30, 2007 was
      12,737,983.





Transitional
      Small Business Disclosure Format (check one): Yes:o
      No:x


1


**EXPLANATORY
      NOTE**





On
      August
      28, 2007, the Chief Financial Officer of Natural Nutrition, Inc. (the
“ Company ”),
      with
      the approval of the Board of Directors of the Company, concluded that the
      consolidated financial statements for the period ended March 31, 2006 included
      in the March 31, 2007 Form 10-QSB filed on May 14, 2007 should no longer be
      relied on.





The
      Company adopted FSP EITF 00-19-2 on January 1, 2007 and incorrectly applied
      the
      new method of accounting for registration payment arrangements retrospectively.
      The new method of accounting for registration payment arrangements should have
      been accounted for prospectively. This resulted in an incorrect presentation
      of
      the consolidated financial statements for the three (3) months ended March
      31,
      2006.





The
      Company discussed the matters disclosed in this filing with the Company’s
      independent accountant. The Company has revised the consolidated financial
      statements by filing an amendment to the March 31, 2007 Quarterly Report on
      Form
      10-QSB.





In
      accordance with Rune 12b-15 of the Securities Exchange Act of 1934, the complete
      text of those items in which amended language appears is set forth herein,
      including those portions of the text that have not been amended from that set
      forth in the original Form 10-QSB. Except for the restatement, this Form
      10-QSB/A does not materially modify or update other disclosures in the original
      Form 10-QSB, including the nature and character of such disclosure to reflect
      events after May 21, 2007, the filing date of the original Form 10-QSB.
      Accordingly this Form 10-QSB/A should be read in conjunction with the Company’s
      other filings made with the Securities and Exchange Commission. Currently date
      certifications from the Company’s Chief Executive Officer and Chief Financial
      Officer have been included as exhibits to this amendment.





2




**NATURAL
      NUTRITION, INC.**


(Formerly
      CSI Business Finance, Inc.)


**FORM
      10-QSB/A**








**INDEX**





Page
              NumberPART
                I - FINANCIAL INFORMATIONItem
                1. Financial StatementsCondensed
                Consolidated Balance Sheet as of March 31, 2007
                (Unaudited)
            4Condensed
                Consolidated Statements of Operations for the three months ended
                March 31,
                2007 and 2006 (Unaudited)
            5Condensed
                Consolidated Statements of Cash Flows for the three months ended
                March 31,
                2007 and 2006 (Unaudited)
            6Notes
                to Condensed Consolidated Financial Statements (Unaudited)
            7-10Item
                2. Management's Discussion and Analysis or Plan of
                Operation
            11-14Item
                3. Controls and Procedures
            14-15PART
                II - OTHER INFORMATIONItem
                1. Legal Proceedings
            15Item
                2. Unregistered Sales of Equity Securities and Use of
                Proceeds
            15Item
                3. Defaults Upon Senior Securities
            15Item
                4. Submission of Matters to a Vote of Security Holders
            15Item
                5. Other Information
            15Item
                6. Exhibits
            16SIGNATURES
            17





3


**PART**  **I
      -FINANCIAL INFORMATION**





**Item
      1. Financial Statements**




**NATURAL
                  NUTRITION, INC. AND SUBSIDIARIES****(Formerly
                  CSI Business Finance, Inc.)****CONDENSED
                  CONSOLIDATED BALANCE SHEET****March
                  31, 2007****(Unaudited)**
  **ASSETS****CURRENT
                  ASSETS**Cash
              
              $
              89,540Notes
                  receivable
              
              
              1,978,142Investment
                  in marketable securities
              
              
              702,782Due
                  from affiliate
              
              
              113,244Prepaids,
                  accrued interest and other accounts receivable
              
              
              112,737Total
                  current assets
              
              
              2,996,445**NONCURRENT
                  ASSETS**Investments
              
              
              9,462,958Fixed
                  assets, net
              
              
              4,292Total
                  noncurrent assets
              
              
              9,467,250**TOTAL
                  ASSETS**
              
              $
              12,463,695**LIABILITIES
                  AND SHAREHOLDERS' DEFICIT****CURRENT
                  LIABILITIES**Accounts
                  payable, accrued liabilities and other current liabilities
              
              $
              260,273Total
                  current liabilities
              
              
              260,273**NONCURRENT
                  LIABILITIES**Debenture
                  payable--net of discount of $331,094
              
              
              15,297,105Derivative
                  liability
              
              
              210,622Accrued
                  interest payable
              
              
              896,934Total
                  liabilities
              
              
              16,664,934**COMMITMENTS
                  AND CONTINGENCIES****SHAREHOLDERS'
                  DEFICIT**Preferred
                  stock, $.01 par value; 10,000,000 shares authorizedPreferred
                  stock Series A Convertible $0.01 par value;100,000
                  shares authorized, 94,443 shares issued and outstanding and
                  noliquidation
                  or redemption value
              
              
              944Common
                  stock, par value $0.001; 10,000,000,000 sharesauthorized;
                  12,737,983 issued and outstanding
              
              
              12,738Additional
                  paid-in capital
              
              
              202,697Retained
                  deficit
              
              
              (4,417,618
              )Total
                  shareholders' deficit
              
              
              (4,201,239
              )**TOTAL
                  LIABILITIES AND SHAREHOLDERS' DEFICIT**
              
              $
              12,463,695


See
      accompanying Notes to the unaudited Condensed Consolidated Financial
      Statements





4


**NATURAL
                  NUTRITION, INC. AND SUBSIDIARIES****(Formerly
                  CSI Business Finance, Inc.)****CONDENSED
                  CONSOLIDATED STATEMENTS OF OPERATIONS****(Unaudited)**
  **Three
                  months ended March 31,****2007**
              
              **2006****REVENUE**Lease
                  income
              
              $
              -
              
              $
              39,684Fee
                  income
              
              
              2,965
              
              
              -Trading
                  gains (losses)
              
              
              3,285
              
              
              (133,773
              )Dividends
                  from marketable securities
              
              
              7,159
              
              
              174,542Interest
                  income from notes and debenture receivable
              
              
              74,058
              
              
              143,430Total
                  revenue
              
              
              87,467
              
              
              223,883**OPERATING
                  EXPENSES**Selling,
                  general and administrative expenses (2007 and 2006include
                  $101,199 and $41,796, respectively of expensesallocated
                  from an affiliated entity)
              
              
              374,113
              
              
              323,359Interest
                  expense
              
              
              249,910
              
              
              244,552**OPERATING
                  LOSS**
              
              
              (536,556
              )
              
              (344,028
              )**OTHER
                  (INCOME) EXPENSE**Net
                  change in fair value of derivative
              
              
              40,368
              
              
              17,258Loss
                  on extinguishment of debenture receivable
              
              
              -
              
              
              639Interest
                  and other income
              
              
              (9,519
              )
              
              19,177Total
                  other expense
              
              
              30,849
              
              
              37,074Loss
                  before provision for income taxes
              
              
              (567,405
              )
              
              (381,102
              )**INCOME
                  TAX PROVISION**
              
              
              -
              
              
              -**NET
                  LOSS APPLICABLE TO COMMON SHARES**
              
              $
              (567,405
              )
              $
              (381,102
              )Net
                  loss per share for basic and diluted
              
              $
              (0.05
              )
              $
              (0.06
              )Weighted
                  shares outstanding for basic and diluted
              
              
              12,579,712
              
              
              6,287,660





See
      accompanying Notes to the unaudited Condensed Consolidated Financial
      Statements


5


**NATURAL
                  NUTRITION, INC. AND SUBSIDIARIES****(Formerly
                  CSI Business Finance, Inc.)****CONDENSED
                  CONSOLIDATED STATEMENTS OF CASH FLOWS****(Unaudited)**
  **Three
                  Months Ended March 31,****2007**
              
              **2006****CASH
                  FLOWS FROM OPERATING ACTIVITIES**Net
                  loss
              
              $
              (567,405
              )
              $
              (381,102
              )Adjustment
                  to reconcile net income to net cashprovided
                  by (used in) operating activities
              
              
              408,254
              
              
              619,526Net
                  cash provided by (used in) operating activities
              
              
              (159,151
              )
              
              238,424**CASH
                  FLOWS FROM INVESTING ACTIVITIES**Sale
                  of asset
              
              
              100,000
              
              
              -Net
                  cash provided by investing activities
              
              
              100,000
              
              
              -**CASH
                  FLOWS FROM FINANCING ACTIVITIES**Payments
                  on notes payable to affiliate
              
              
              -
              
              
              (181,988
              )Net
                  cash used in financing activities
              
              
              -
              
              
              (181,988
              )**NET
                  CHANGE IN CASH**
              
              
              (59,151
              )
              
              56,436**CASH,
                  BEGINNING OF PERIOD**
              
              
              148,691
              
              
              204,243**CASH,
                  END OF YEAR**
              
              $
              89,540
              
              $
              260,679**SUPPLEMENTAL
                  INFORMATION**Interest
                  paid
              
              $
              710
              
              $
              51,789Taxes
                  paid
              
              $
              -
              
              $
              -Exchange
                  of certain receivable for common stock:Common
                  stock acquired
              
              $
              -
              
              $
              9,887,959Debentures
                  and notes receivable exchanged
              
              $
              -
              
              $
              9,609,283Accrued
                  interest receivable exchanged
              
              $
              -
              
              $
              278,676


See
      accompanying Notes to the unaudited Condensed Consolidated Financial
      Statements


6


**Natural
      Nutrition, Inc. and Subsidiaries**


**(Formerly
      CSI Business Finance, Inc.)**


**Notes
      to Condensed Consolidated Financial Statements**


**(Unaudited)**




**NOTE
      1**  **-
      BASIS OF PRESENTATION**





Our
      Condensed Consolidated Balance Sheet as of March 31, 2007, the Condensed
      Consolidated Statements of Operations for the three months ended March 31,
      2007
      and March 31, 2006, and the Condensed Consolidated Statements of Cash Flows
      for
      the three months ended March 31, 2007 and March 31, 2006 have not been audited.
      These statements have been prepared on a basis that is substantially consistent
      with the accounting principles applied in our Annual Report on Form 10-KSB
      for
      the fiscal year ended December 31, 2006. In our opinion, these financial
      statements include all normal and recurring adjustments necessary for a fair
      presentation of Natural Nutrition, Inc. (the “Company”) and Subsidiaries. The
      results for the three months are not necessarily indicative of the results
      expected for the year.





As
      used
      herein, the “Company”, “management”, “we”, “our” refers to Natural Nutrition,
      Inc., or Natural Nutrition, Inc. together with its subsidiaries. The Company's
      fiscal year ends on December 31st.




Certain
      information and footnote disclosures normally included in financial statements
      prepared in accordance with accounting principles generally accepted in the
      United States of America have been omitted in accordance with the published
      rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”)
      for interim financial statements. The unaudited Condensed Consolidated Financial
      Statements and the notes thereto in this report should be read in conjunction
      with the audited Consolidated Financial Statements and notes thereto included
      in
      our Annual Report on Form 10-KSB for the fiscal year ended December 31,
      2006 (the “10-KSB”).





Natural
      Nutrition, Inc. (the “Company”), formerly CSI Business Finance, Inc., formerly
      Health Express USA, Inc., was incorporated in Florida on July 2, 1998. On August
      25, 2005, the Company completed the closing of that certain Share Exchange
      Agreement, by and between the Company, CSI Business Finance, Inc., a Texas
      corporation and now wholly-owned subsidiary of the Company herein referred
      to as
      ("CSI") and the shareholder of CSI (the "CSI Shareholder").





On
      August
      25, 2005, the Company effectively exchanged with the CSI Shareholder the issued
      and outstanding common stock of CSI in exchange for 100,000 shares of Series
      A
      Convertible Preferred Stock, par value $0.01 per share, of the Company, and
      CSI
      became a wholly-owned subsidiary of the Company. Each share of the Company's
      Series A Preferred Stock is convertible into 780 shares of common stock of
      the
      Company, beginning one year after the effective date of the merger. The
      Preferred shares were subsequently distributed to the shareholders of Corporate
      Strategies, Inc., the former shareholder of CSI. In addition, at the exchange
      date, 4,326,861 shares of common stock of the Company were issued to pay off
      notes and debentures. If the preferred shareholders were to convert to common
      stock as of the date of the merger, they would hold 78,000,000 shares, or
      ninety-two and one half percent (92.5%) of the issued and outstanding shares
      of
      common stock of the Company. This conversion would result in the Series A
      Preferred Shareholders effectively controlling the Company.





The
      Series A Convertible Preferred Shareholders and the holders of the common stock
      of the Company vote together and not as separate classes, and the Preferred
      Stock shall be counted on an "as converted" basis, thereby giving the Preferred
      Shareholders control of the Company. The transaction was accounted for as a
      reverse acquisition since control of the Company passed to the shareholders
      of
      the acquired company (CSI).





The
      Company was subsequently renamed in 2005 to CSI Business Finance, Inc. (the
      Florida corporation). In September of 2006, CSI Business Finance, Inc. changed
      its name to Natural Nutrition, Inc. and simultaneously redomiciled from Florida
      to Nevada.





On
      May
      23, 2006, our Board of Directors approved a 1 for 25 reverse common stock split.
      All references to our common stock in this document are stated in shares after
      the reverse split.





The
      accompanying unaudited condensed consolidated financial statements for prior
      years contain certain reclassifications to conform with current year
      presentation.





The
      unaudited condensed consolidated financial statements include the accounts
      of
      the Company and its wholly-owned subsidiaries. All significant inter-company
      accounts and transactions have been eliminated in consolidation.





In
      December 2006, the Financial Accounting Standards Board (“FASB”) issued FASB
      Staff Position on No. EITF 00-19-2, Accounting for Registration Payment
      Arrangements (“FSP EITF 00-19-2”). FSP EITF 00-19-2 provides that the contingent
      obligation to make future payments or otherwise transfer consideration under
      a
      registration payment arrangement should be separately recognized and measured
      in
      accordance with Statement of Financial Accounting Standards (“FAS”) No. 5,
      Accounting for Contingencies, which provides that loss contingencies should
      be
      recognized as liabilities if they are probable and can be reasonably estimated.
      Subsequent to the adoption of FSP EITF 00-19-2, any changes in the carrying
      amount of the contingent liability will result in a gain or loss that will
      be
      recognized in the consolidated statement of operations in the period the changes
      occur. The guidance in




7


FSP
      EITF
      00-19-2 is effective immediately for registration payment arrangements and
      the
      financial instruments subject to those arrangements that are entered into or
      modified subsequent to the date of issuance of FSP EITF 00-19-2. For
      registration payment arrangements and financial instruments subject to those
      arrangement that were entered into prior to the issuance of FSP EITF 00-19-2,
      this guidance is effective for our consolidated financial statements issued
      for
      the year beginning January 1, 2007, and interim periods within that
      year.





On
      January 1, 2007, we adopted the provisions of FSP EITF 00-19-2 to account for
      our registration payment arrangements. As of January 1, 2007 and March 31,
      2007,
      management determined that is was not probable that we would have any payment
      obligation under our registration payment arrangements; therefore, no accrual
      for contingent obligation is required under the provisions of FSP EITF 00-19-2.
      Accordingly, these amended comparative condensed consolidated financial
      statements have been adjusted to apply the new method prospectively. The
      following financial statement line items for the three months ended March 31,
      2007 were affected by the change in accounting principle:





**Consolidated
                  Statements of Operations**As
                  Computed
              
              As
                  Reportedunder
              
              under
                  FSP
              
              Effect
                  ofEITF
                  00-19
              
              EITF
                  00-19-2
              
              Change**Three
                  months ended March 31, 2007**Loss
                  from operations
              
              $
              (561,203
              )
              $
              (536,556
              )
              $
              (24,647
              )Net
                  change in fair value of derivative
              
              
              40,368
              
              
              40,368
              
              
              -Net
                  loss
              
              
              (592,052
              )
              
              (567,405
              )
              
              (24,647
              )Net
                  loss per share
              
              
              (0.05
              )
              
              (0.05
              )
              
              (0.00
              )**Consolidated
                  Balance Sheet****March
                  31, 2007**Debenture
                  payable - net of discount
              
              $
              15,126,529
              
              $
              15,297,105
              
              $
              170,576Derivative
                  liability
              
              
              381,198
              
              
              210,622
              
              
              (170,576
              )Total
                  liabilities and shareholders' deficit
              
              
              12,463,695
              
              
              12,463,695
              
              
              -**Consolidated
                  Statements of Cash Flows****March
                  31, 2007**Net
                  loss
              
              $
              (592,052
              )
              $
              (567,405
              )
              $
              24,647Net
                  change in fair value of derivatives andamortization
                  of debt discount.
              
              
              74,311
              
              
              49,664
              
              
              (24,647
              )


8





**NOTE
      2. INCOME (LOSS) PER COMMON SHARE AND STOCK BASED
      COMPENSATION**




**Net
      Income (Loss) Per Common Share**




In
      accordance with SFAS No. 128, "Earnings per Share", basic earnings per share
      are
      computed based on the weighted average shares of common stock outstanding during
      the periods.  Diluted earnings per share are computed based on the weighted
      average shares of common stock plus the assumed issuance of common stock for
      all
      potentially dilutive securities.





Our
      basic
      and diluted shares used to compute loss per common share amounts are the same
      for both the three months ended March 31, 2007 and March 31, 2006. Since we
      had
      a net loss for the three months ended March 31, 2007 and March 31, 2006, the
      assumed exercise of stock options and the conversion of the Series A Preferred
      Stock and secured convertible debentures outstanding as of March 31, 2007 and
      March 31, 2006 would be anti-dilutive.





**Stock
      Based Compensation**




Statement
      of Financial Accounting Standards No. 123(R), “Accounting for Stock-Based
      Compensation” (“SFAS 123(R)”), provides for the use of a fair value-based method
      of accounting for employee stock compensation. There are outstanding stock
      options to purchase 5,695 of the Company's common stock at an exercise price
      of
      $32.75 per share. These options expire in August 2007. We believe these options
      do not have a fair market value and we expect them to be forfeited.




**NOTE
      3**  **-
      AGREEMENT IN LIEU OF FORECLOSURE**




On
      September 5, 2005, CSI Business Finance, Inc purchased the senior secured debt
      of Bio One Corporation for $9,600,000. The Company originally planned to profit
      from this transaction based on its ability to convert the debt purchased into
      Bio One common stock at a twenty percent discount to the market price of the
      Bio
      One common stock. However, Bio One common stock stopped trading some time after
      the note purchase was complete, and CSI Business Finance, Inc had to look to
      the
      assets underlying the note purchased for repayment as Bio One was no longer
      a
      viable enterprise.  On March 22, 2006, the Company completed an agreement
      in lieu of foreclosure (the “Agreement”) with Bio One Corporation (“Bio-One”)
      and received the stock of Interactive Nutrition International, Inc. (“INII”),
      along with other assets and claims, in return for the forgiveness of $9,887,959
      in debt and accrued interest of Bio-One which is now being treated as an
      investment in INII. INII is currently being operated by PriceWaterhouseCoopers
      (“PWC”) as Receiver and Manager pursuant to Section 246(2) of the Bankruptcy and
      Insolvency Act of Canada, after being requested to do so by Nesracorp Inc.,
      Eli
      Nesrallah, Joseph Nesrallah and Pamela Nesrallah (collectively, the “Sellers”),
      purporting  default in payment of obligations incurred in the purchase of
      INII assets  by Bio-One. A Court-supervised sale of the assets has been
      requested by the Receiver, and the Company has vigorously opposed this and
      pursued numerous damage claims against the Sellers. Additionally, the Company
      has been assigned all rights and claims previously asserted against the Sellers,
      Roxanne Anderson and PWC filed by INII and Bio-One in the Ontario Superior
      Court
      of Justice on January 13, 2005. The Company intends to pursue some or all
      of the previous claims in the filing of January 13, 2005 in Ontario Superior
      Court of Justice, as the stock of INII and these claims, as well as others,
      have
      been assigned to the Company as part of the Agreement the Company executed
      with
      Bio-One on March 22, 2006.




On
      May 5,
      2006, the Board of Directors terminated the Nesrallahs as employees of the
      Company. On March 30, 2006, the Company filed a lawsuit in State Court in
      Orlando, Florida against the Nesrallahs, alleging, among other claims, breach
      of
      fiduciary duty to INII. As of the date of this filing, the Florida action has
      been abated pending the outcome of the results of our agreement in lieu of
      foreclosure disclosed in our Current Report on Form 8-K filed on January 12,
      2007. On March 31, 2007, management was successful in extending the letter
      of
      intent to May 4, 2007. As of the date of this filing, the agreement has expired
      in accordance with its terms. Management is attempting to obtain an extension
      of
      the expired agreement, but there can be no assurances that this will occur.
      No
      reserve has been established for a loss on this transaction, as the Company
      believes its claims are meritorious and have a reasonable probability
      of prevailing in a Court of law, or of entering into a mutually agreeable
      settlement. We have reduced our investment by $350,000 in 2006 and an additional
      $100,000 in the first quarter of 2007 for proceeds from the sale of an
      asset.  However, should the Company fail to prevail or settle its claims
      against the Seller’s, the Company will be required to write down its entire
      investment of $9,437,959 in INII. **Shareholders
      are cautioned that the loss of this investment could result in the complete
      failure of the Company and foreclosure of its remaining assets by its lender.**





**NOTE
      4 - CONVERTIBLE DEBENTURES PAYABLE AND DERIVATIVE FINANCIAL INSTRUMENTS**




Effective
      September 9, 2005, the Company issued a secured convertible debenture (the
      "Debenture") to Cornell Capital Partners, LP in the amount of $15,635,199.
      The
      notes bear interest at 5%, which is accrued until maturity on September 8,
      2008.
      The note is convertible, at the option of the holders, into common stock of
      the
      Company at a price of $0.09 per share, subject to standard anti-dilution
      provisions relating to splits, reverse splits and other transactions plus a
      reset provision whereby the conversion prices may be adjusted downward to a
      lower price per share based on the average of the three lowest closing prices
      for the five trading days prior to conversion. The Holder has the right to
      cause
      the notes to be converted into common stock, subject to an ownership limitation
      of 4.99% of the outstanding stock. The Company has the right to repurchase
      the
      Notes at 106% of the face amount.




9




The
      derivatives from the debenture payable has been accounted for in accordance
      with
      SFAS 133 and EITF No. 00-19, "Accounting for Derivative Financial Instruments
      Indexed to, and Potentially Settled in, a Company's Own Stock."





The
      Company has determined that the following instrument has derivatives requiring
      evaluation and accounting under the relevant guidance applicable to financial
      derivatives:





·
            Cornell
                Debenture Payable issued 9/9/05 in the face amount of
                $15,635,199





The
      Company has identified that the above debenture has embedded derivatives. These
      embedded derivatives have been bifurcated from their respective host debt
      contracts and accounted for as derivative liabilities in accordance with EITF
      00-19. When multiple derivatives exist within the Convertible Debentures, they
      have been bundled together as a single hybrid compound instrument in accordance
      with SFAS No. 133 Derivatives Implementation Group Implementation Issue No.
      B-15, "Embedded Derivatives: Separate Accounting for Multiple Derivative
      Features Embedded in a Single Hybrid Instrument."




The
      embedded derivatives within the Convertible Debenture has been recorded at
      fair
      value at the date of issuance; and are marked-to-market each reporting period
      with changes in fair value recorded to the Company's income statement as "Net
      change in fair value of derivatives." The Company has utilized a third party
      valuation firm to fair value the embedded derivatives using a layered discounted
      probability-weighted cash flow approach. The fair value model utilized to value
      the various embedded derivatives in the Convertible Debenture, comprises
      multiple probability-weighted scenarios under various assumptions reflecting
      the
      economics of the Convertible Debenture, such as the risk-free interest rate,
      expected Issuer stock price and volatility, likelihood of conversion and or
      redemption, and likelihood default status.





The
      fair
      value of the derivative liabilities are subject to the changes in the trading
      value of the Company's common stock, as well as other factors. As a result,
      the
      Company's financial statements may fluctuate from quarter-to-quarter based
      on
      factors, such as the price of the Company's stock at the balance sheet date
      and
      the amount of shares converted by the debenture holders. Consequently, our
      financial position and results of operations may vary from quarter-to-quarter
      based on conditions other than our operating revenues and expenses.





The
      conversion feature, reset provision and the Company’s optional early redemption
      right to the debenture payable have been bundled together as a single compound
      embedded derivative liability, and using a layered discounted
      probability-weighted cash flow approach, was initially fair valued at $413,603
      at September 9, 2005. Using the same methodology, the single compound embedded
      derivative liability was valued at $210,622 at March 31, 2007. For the period
      since December 31, 2006 through March 31, 2007, the change in fair value of
      the
      derivative liability was a decrease of $40,368, which has been classified as
      net
      change in fair value of derivative.





The
      above
      compound embedded derivative plus the loan costs paid the lender in the amount
      of $687,832 are recorded as a discount against the notional carrying amount
      of
      the debenture payable. The unamortized discount is being amortized over the
      term
      of the note using the effective interest method. Recorded in interest expense
      for this amortization is $56,524 at March 31, 2007 and $53,295 at March 31,
      2006.





**Note
      5 - RESTATEMENT OF MARCH 31, 2006 FINANCIAL STATEMENTS**





Natural
      Nutrition, Inc., fka CSI Business Finance, Inc., (the “Company”) is filing this
      Amendment No. 1 to its Quarterly Report on Form 10-QSB for the quarter ended
      March 31, 2007 to restate the financial results and Note 1 - Basis of
      Presentation. The restatement removes the effect of the provisions of FSP EITF
      00-19-2 to account for our registration payment arrangements for the three
      months ended March 31, 2006. The Company adopted FSP EITF 00-19-2 on January
      1,
      2007 and incorrectly applied the new method of accounting for registration
      payment arrangements retrospectively. The new method of accounting for
      registration payment arrangements should have been accounted for prospectively.
      This resulted in an incorrect presentation of the consolidated financial
      statements for the three (3) months ended March 31, 2006.





Adjustments
      were recorded to remove the effect of the retroactive entries to apply FSP
      EITF
      00-19-2 to Net change in fair value of derivative $61,509 for the three months
      ended March 31, 2006. This item affected the income statement and statement
      of
      cash flows only for the three months ended March 31, 2006. The effect of the
      restatement was to change the income statement and cash flows for March 31,
      2006
      to the originally filed statements in the March 31, 2006 Form 10-QSB.





10




**ITEM
                2****.**
            **MANAGEMENT'S
                DISCUSSION AND ANALYSIS OR PLAN OF
                OPERATION.**




**FORWARD-LOOKING
      STATEMENTS AND ASSOCIATED RISKS**





This
      Quarterly Report on Form 10-QSB, and the accompanying MD&A, contains
      forward-looking statements.  Statements contained in this report about
      Natural Nutrition, Inc.'s future outlook, prospects, strategies and plans,
      and
      about industry conditions and demand for our financial services are
      forward-looking.  All statements that express belief, expectation,
      estimates or intentions, as well as those that are not statements of historical
      fact, are forward looking. The words "proposed," "anticipates," "anticipated,"
      "will," "would," "should," "estimates" and similar expressions are intended
      to
      identify forward-looking statements.  Forward-looking statements represent
      our reasonable belief and are based on our current expectations and assumptions
      with respect to future events. While we believe our expectations and assumptions
      are reasonable, they involve risks and uncertainties beyond our control that
      could cause the actual results or outcome to differ materially from the expected
      results or outcome reflected in our forward-looking statements.  In light
      of these risks, uncertainties and assumptions, the forward-looking events
      discussed in this quarterly report may not occur.  Such risks and
      uncertainties include, without limitation, our successful efforts in the outcome
      of our litigation concerning our investment in INII, or the extension of our
      agreement in lieu of foreclosure, our success in trading marketable securities,
      our ability to maintain contracts that are critical to our operations, actual
      customer demand for our financing and related services, collection of accounts
      and notes receivable, our ability to obtain and maintain normal terms with
      our
      vendors and service providers and conditions in the capital markets and equity
      markets during the periods covered by the forward-looking
      statements.





The
      forward-looking statements contained in this report speak only as of the date
      hereof.  We undertake no obligation to publicly update or revise any
      forward-looking statements, whether as a result of new information, future
      events or any other reason.  All forward-looking
      statements attributable to Natural Nutrition, Inc. or any person acting on
      its
      behalf are expressly qualified in their entirety by the cautionary statements
      contained or referred to in our annual report filed on Form 10-KSB and in our
      future periodic reports filed with the SEC. The following M,D&A should be
      read in conjunction with these unaudited Condensed Consolidated Financial
      Statements of the Company, and the related notes thereto included elsewhere
      herein, and in conjunction with our audited financial statements, together
      with
      footnotes and the M,D&A, in our 2006 annual report filed on Form 10-KSB with
      the Securities Exchange Commission (the “SEC”).





**Overview**




On
      August
      25, 2005, Health Express USA, Inc., a Florida corporation, entered into a share
      exchange agreement with CSI Business Finance, Inc., a Texas corporation (“CSI”)
      and the shareholder of CSI (Corporate Strategies, Inc.). The transaction is
      being reflected as a reverse acquisition since control of the Company has passed
      to the shareholders of Corporate Strategies, Inc. (“Corporate Strategies”). The
      Company was subsequently renamed in 2005 to CSI Business Finance, Inc. (the
      Florida corporation). In September of 2006 CSI Business Finance, Inc. changed
      its name to Natural Nutrition, Inc. and simultaneously redomiciled from Florida
      to Nevada.





On
      May
      23, 2006, our Board of Directors approved a 1 for 25 reverse split of our common
      stock. All references to our common stock in this document are stated in shares
      after the reverse split.





Since
      CSI
      is the surviving entity of the reverse merger, the financial reports include
      the
      operating results of CSI for the entire year 2005 and the results of operations
      for the period August 25, 2005 through December 31, 2005 for the Company. The
      March 31, 2006 financial statements of the Company represent the condensed
      consolidated results of operations for the entire quarter. All significant
      intercompany accounts and transactions have been eliminated in
      consolidation.





At
      present our Company, through our operating subsidiary, primarily generates
      cash
      and revenue from financing and investing activities. To date these activities
      have included equipment leasing, factoring, loan brokerage activities earned
      in
      originating and selling business leases, providing short term secured lending,
      and investing in marketable securities. Competition for the services we provide
      comes mainly from financial institutions that provide factoring services,
      equipment leases and small business loans, many of which have substantially
      more
      capital resources than our Company.





We
      also
      actively trade marketable securities and options with available cash, and on
      margin, through a third party investment advisor. Because our trading involves
      leveraging, these transactions contain a considerable amount of
      risk.





Management
      of the Company mitigates its risk in lending by securing loans with pledged
      assets (collateral) that, when liquidated, have a reasonable probability of
      realizing proceeds that would retire the liability. In some instances, we obtain
      personal guarantees from individuals of net worth which are adequate to repay
      the liability in the event of default. Additionally, in the example of public
      company finance, we utilize conversion features at a substantial discount to
      the
      market in the event of default that would enable us to realize adequate proceeds
      from the sale of the borrower's stock to repay the liability to the Company.
      Over the long term, management would like to concentrate its efforts on growing
      the business of INII, our largest asset.





11


On
      September 5, 2005, CSI Business Finance, Inc purchased the senior secured debt
      of Bio One Corporation for $9,600,000. The Company originally planned to profit
      from this transaction based on its ability to convert the debt purchased into
      Bio One common stock
      at
      a twenty percent discount to the market price of the Bio One common stock.
      However, Bio One common stock stopped trading
      some time after the note purchase was complete, and CSI Business Finance, Inc
      had to look to the assets underlying the note purchased for repayment as Bio
      One
      was no longer a viable enterprise.  On March 22, 2006, the Company
      completed an agreement in lieu of foreclosure (the “Agreement”) with Bio One
      Corporation (“Bio-One”) and received the stock of INII, along with other assets
      and claims, in return for the forgiveness of $9,887,959 in debt and accrued
      interest of Bio-One which is now being treated as an investment in INII. INII
      is
      currently being operated by PriceWaterhouseCoopers (“PWC”) as Receiver and
      Manager pursuant to Section 246(2) of the Bankruptcy and Insolvency Act of
      Canada, after being requested to do so by Nesracorp Inc., Eli Nesrallah, Joseph
      Nesrallah and Pamela Nesrallah (collectively, the “Sellers”), purporting
 default in payment of obligations incurred in the purchase of INII assets
 by Bio-One. A Court-supervised sale of the assets has been requested by
      the Receiver, and the Company has vigorously opposed this and pursued
      numerous damage claims against the Sellers. Additionally, the Company has been
      assigned all rights and claims previously asserted against the Sellers, Roxanne
      Anderson and PWC filed by INII and Bio-One in the Ontario Superior Court of
      Justice on January 13, 2005. The Company intends to pursue some or all of
      the previous claims in the filing of January 13, 2005 in Ontario Superior Court
      of Justice, as the stock of INII and these claims, as well as others, have
      been
      assigned to the Company as part of the Agreement the Company executed with
      Bio-One on March 22, 2006.




On
      May 5,
      2006, the Board of Directors terminated the Nesrallahs as employees of the
      Company. On March 30, 2006, the Company filed a lawsuit in State Court in
      Orlando, Florida against the Nesrallahs, alleging, among other claims, breach
      of
      fiduciary duty to INII. As of the date of this filing, the Florida action has
      been abated pending the outcome of the results of our agreement in lieu of
      foreclosure disclosed in our Current Report on Form 8-K filed on January 12,
      2007. On March 31, 2007, management was successful in extending the letter
      of
      intent to May 4, 2007. As of the date of this filing, the agreement has expired
      in accordance with its terms.





Management
      is attempting to obtain an extension of the expired agreement, but there can
      be
      no assurances that this will occur. No reserve has been established for a loss
      on this transaction, as the Company believes its claims are meritorious and
      have
      a reasonable probability of prevailing in a Court of law, or of entering
      into a mutually agreeable settlement. We
      have
      reduced our investment by $350,000 in 2006 and an additional $100,000 in the
      first quarter of 2007 for proceeds from the sale of an asset. However,
      should the Company fail to prevail or settle its claims against the Seller’s,
      the Company will be required to write down its entire investment of $9,437,959
      in INII. **Shareholders
      are cautioned that the loss of this investment could result in the complete
      failure of the Company and foreclosure of its remaining assets by its lender.**





As
      a
      result of the above foreclosure, the Company has recorded a $9,887,959
      investment in the INII stock consisting of an $8,500,000 debenture receivable,
      $1,109,283 notes receivable and $278,676 of accrued interest receivable. We
      have
      reduced our investment by $450,000 for proceeds from the sale of an
      asset.





Recent
      Accounting Pronouncements





In
      February 2007, the FASB issued FASB Statement No. 159, *Establishing the Fair Value Option for Financial Assets and
      Liabilities* (“SFAS
      159”) *,* to
      permit all entities to choose to elect to measure eligible financial instruments
      at fair value. SFAS 159 applies to fiscal years beginning after November 15,
      2007, with early adoption permitted for an entity that has also elected to
      apply
      the provisions of SFAS 157, *Fair
      Value Measurements* . An
      entity is prohibited from retrospectively applying SFAS 159, unless it chooses
      early adoption. Management is currently evaluating the impact of SFAS 159 on
      the
      consolidated financial statements.





**RESULTS
      OF OPERATIONS**





**Three
      Months Ended March 31, 2007 and March 31, 2006**




We
      had no
      leasing income for the three months ended March 31, 2007 (the “1Q ’07 Period”).
      Leasing income for the three months ended March 31, 2006 (the “1Q ’06 Period”)
      was $39,684. We may continue to seek leasing opportunities in the future,
      however, this is not the primary focus of management, or the Company’s
      resources. Fee income from brokerage fees earned in originating and selling
      business leases and loans was $2,965 for the 1Q ’07 Period versus $0 for the 1Q
’06 Period.





Interest
      Income was $74,058 for the 1Q ‘07 Period as compared to $143,430 in the 1Q ‘06
      Period. Interest income was derived mainly from notes receivable relating to
      receivables factoring and investments as well as interest from a debenture
      and
      notes that were subsequently traded on March 22, 2006 for stock in a Canadian
      subsidiary of the maker of the debentures. Dividend income was $7,159 for the
      1Q
‘07 Period and $174,542 for the 1Q ‘06 Period. Dividend income is primarily
      derived from various investments in marketable securities. For the 1Q ‘07
      Period, we recorded net trading gains from various investments in marketable
      securities in the


amount
      of
      $3,285. Of the gains for the 1Q ’07 Period, $1,453 were realized trading losses
      while $4,738 were unrealized trading gains. For the 1Q ‘06 Period, we recorded
      $133,773 in net trading losses, $464,674 in realized trading losses and $330,901
      in unrealized trading gains. We actively trade marketable securities and
      consider trading to be a source of future revenue. The Company has taken steps
      to protect its portfolio with the use of put and call options to limit the
      risk
      of losses in the future, while maximizing upside potential.




We
      have
      not yet reached the size to benefit from separate office space and a dedicated
      staff. Our Company shares office space and certain administrative functions
      and
      staff with an affiliated company. Costs are allocated for these shared functions
      are based on an estimate of time usage.




12





Our
      operating expenses were $624,023 for the 1Q ‘07 Period as compared to $567,911
      for the 1Q ‘06 Period.





Salaries
      and Benefits were $106,538 for the 1Q ’07 Period versus $83,561 for the 1Q ‘06
      Period. The primary reason for the increase was the hiring of a part time CFO
      in
      the third quarter of our calendar year 2006, a new transaction principal in
      January of 2007 and an increase in salary to our CEO and another employee,
      less
      salaries allocated in prior quarters.




Professional
      fees were $60,764 in the 1Q ‘07 Period as compared to $151,737 for the 1Q ‘06
      Period. The difference is primarily a result of legal fees incurred for our
      INII
      litigation in the first quarter of 2006.




Interest
      expense was $249,910 for the 1Q ’07 Period and $244,552 for the 1Q ‘06 Period.
      Interest expense primarily relates to the expense associated with the
      $15,635,199 five percent (5%) convertible debenture entered into in September
      2005 to fund INII and interest on our margin loan.





The
      Company was allocated overhead from an affiliate in the amount of $101,199
      for
      the 1Q ‘07 Period as compared to $41,796 for the 1Q ‘06 Period. The increase in
      the overhead allocation is primarily due to the amount of due diligence expended
      on the INII transaction from members of our affiliate. No contractual
      arrangement exists between the two companies.





**Liquidity
      and Capital Resources**  ****





Operating
      Activities





We
      incurred a net loss for the three months ended March 31, 2007 in the amount
      of
      $567,405. During the three months ended March 31, 2007, our operations used
      cash
      flow in the amount of $159,151. Our
      uses
      in operating cash flow was primarily by an increase in notes receivable
      ($178,921) an increase in amounts due from affiliates ($29,167) and an increase
      in prepaid expenses ($50,730). Cash flow from operating activities was generated
      primarily from a decrease in the value of our investments in marketable
      securities ($391,855) and an increase in accrued liabilities
      ($144,263).





Investing
      Activities





We
      realized $100,000 in proceeds from the sale of assets. The asset was included
      as
      a part of our investment in INII. A receivable for this asset was not recorded
      when our original investment in INII was made. The proceeds from the collection
      of this loan were charged to our investment in INII.





Financing
      Activities





For
      the
      three months ended March 31, 2007, there were no cash flows from financing
      activities.





The
      Company had working capital in the amount of $2,736,172 at March 31, 2007.
      Included in our working capital is $1,978,142 of short term notes receivable
      and
      $702,782 in investments in marketable securities. For the three months ended
      March 31, 2007 we made $175,000 of loans to two new clients.





Our
      cash
      flows for the periods are summarized below:





Three
                Months Ended
            Three
                Months EndedMarch
                31, 2007
            March
                31, 2006Net
                cash provided by (used) in operating activities
            
            
            $(159,151)
            $238,424Net
                cash provided by investing activities
            
            
            $100,000
            $0Net
                cash used in financing activities
            
            
            $0
            $(181,988)





Our
      cash
      decreased $59,151 since December 31, 2006.





Management
      believes the Company has adequate working capital and cash to be provided from
      operating activities to fund current levels of operations. We anticipate that
      our company will grow. As our business grows we believe that we will have to
      raise additional capital in the private debt and public equity markets to fund
      our investments.




**Off-Balance
      Sheet Arrangements**




The
      Company had no off-balance sheet arrangements or guarantees of third party
      obligations at March 31, 2007.




13


**Inflation**




The
      Company believes that inflation has not had a significant impact on operations
      since inception.





**ITEM
      3. CONTROLS AND PROCEDURES**




**(A)
      Evaluation of Disclosure Controls and Procedures**




The
      Company maintains disclosure controls and procedures designed to ensure that
      information required to be disclosed in reports filed under the Securities
      Exchange Act of 1934, as amended, is recorded, processed, summarized,
      accumulated and communicated to the Company’s management, including its Chief
      Executive Officer ("CEO") and Chief Financial Officer ("CFO"), as appropriate,
      to allow timely decisions regarding required disclosure.




As
      of the
      end of the period covered by this report, the Company's management carried
      out
      an evaluation, under the supervision and with the participation of the Company's
      Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the
      effectiveness of the design and operation of the Company's system of disclosure
      controls and procedures pursuant to the Securities and Exchange Act, Rule
      13a-15(e) and 15d-15(e) under the Exchange Act). Based on the material
      weaknesses described herein the Company's CEO and CFO have concluded that the
      Company's disclosure controls and procedures were not effective, as of the
      date
      of that evaluation, for the purposes of recording, processing, summarizing
      and
      timely reporting of material information required to be disclosed in reports
      filed by the Company under the Exchange Act. Because of our size, the Company
      shares its accounting staff with an affiliated company and is comprised of
      its
      part-time Chief Financial Officer, controller and data entry clerk. The
      controller and data entry clerk are considered contract employees whom also
      work
      for an affiliated company as contract employees. Our CFO is also an employee
      of
      an affiliate. Because of the structure of our staff, we have a failure to
      maintain effective controls over the selection, application and monitoring
      of
      our accounting policies to assure that certain complex equity transactions
      were
      accounted for in accordance with generally accepted accounting
      principles.




**(B)
      Changes**  **in
      Internal Controls over Financial Reporting**




In
      connection with the evaluation of the Company's internal controls during the
      Company's last fiscal quarter covered by this report, the Company's CEO and
      CFO
      have determined that there were no changes to the Company's internal controls
      over financial reporting that have materially affected, or are reasonably likely
      to materially effect, the Company's internal controls over financial
      reporting.





**Material
      Weaknesses Identified**




In
      connection with the audit of our consolidated financial statements for the
      fiscal year ended December 31, 2006, our independent registered public
      accounting firm informed us that we have significant deficiencies constituting
      material weaknesses. As defined by the Public Company Accounting Oversight
      Board
      Auditing Standard No. 2, a material weakness is a significant control
      deficiency or a combination of significant control deficiencies that result
      in
      there being more than a remote likelihood that a material misstatement in the
      annual or interim financial statements will not be prevented or detected. The
      material weaknesses identified by the auditor during the December 31, 2005
      and
      2006 audit were the lack of segregation of duties necessary to maintain proper
      checks and balances between functions and the lack of procedures to properly
      account for non-routine transactions and preparation of certain financial
      statement disclosures in accordance with U.S. GAAP. The absence of qualified
      full time accounting personnel was a contributing factor to the problems
      identified by the auditor. The specific circumstances giving rise to the
      weaknesses include utilizing the services of contract accountants on a part
      time
      basis in the absence of internal accounting personnel.





Further,
      based on the material weaknesses described herein, we concluded that our
      disclosure controls and procedures were not effective at March 31, 2007, the
      end
      of this reporting period..





**Remediation
      Plan regarding the Material Weaknesses**





The
      Company has taken the following steps to address the specific problems
      identified by the auditors:




(1)
            Our
                affiliate has hired of a Chief Financial Officer and a contract part-time
                bookkeeper to allow us to properly implement the segregation of duties
                necessary to maintain checks and balances between accounting and
                Executive
                functions.




(2)
            All
                non-routine transactions will be reviewed by our Chief Financial
                Officer and, contract controller before they are
                completed.





(3)
            The
                Company will emphasize enhancement of the segregation of duties based
                on
                the limited resources the Company has, and, where practical, the
                Company
                will continue to access the cost versus benefit of adding additional
                resources that would mitigate the situation. Our Chief Financial
                Officer
                will monitor our accounting policies to assure proper accounting
                for
                financial derivatives and other unusual transactions on an ongoing
                basis.




14


The
      Company continues its efforts to remediate control weaknesses and further
      improve and strengthen its internal control over financial reporting under
      the
      direction of the CEO and the CFO.





**PART
      II - OTHER INFORMATION**





**ITEM
      1**  **.
      LEGAL PROCEEDINGS**





On
      September 5, 2005, CSI Business Finance, Inc purchased the senior secured debt
      of Bio One Corporation for $9,600,000. The Company originally planned to profit
      from this transaction based on its ability to convert the debt purchased into
      Bio One common stock at a twenty percent discount to the market price of the
      Bio
      One common stock. However, Bio One common stock stopped trading some time after
      the note purchase was complete, and CSI Business Finance, Inc had to look to
      the
      assets underlying the note purchased for repayment as Bio One was no longer
      a
      viable enterprise.  On March 22, 2006, the Company completed an agreement
      in lieu of foreclosure (the “Agreement”) with Bio One Corporation (“Bio-One”)
      and received the stock of INII, along with other assets and claims, in return
      for the forgiveness of $9,887,959 in debt and accrued interest of Bio-One which
      is now being treated as an investment in INII. INII is currently being operated
      by PriceWaterhouseCoopers (“PWC”) as Receiver and Manager pursuant to Section
      246(2) of the Bankruptcy and Insolvency Act of Canada, after being requested
      to
      do so by Nesracorp Inc., Eli Nesrallah, Joseph Nesrallah and Pamela Nesrallah
      (collectively, the “Sellers”), purporting  default in payment of
      obligations incurred in the purchase of INII assets  by Bio-One. A
      Court-supervised sale of the assets has been requested by the Receiver, and
      the
      Company has vigorously opposed this and pursued numerous damage claims
      against the Sellers. Additionally, the Company has been assigned all rights
      and
      claims previously asserted against the Sellers, Roxanne Anderson and PWC filed
      by INII and Bio-One in the Ontario Superior Court of Justice on January 13,
      2005. The Company intends to pursue some or all of the previous claims in the
      filing of January 13, 2005 in Ontario Superior Court of Justice, as the stock
      of
      INII and these claims, as well as others, have been assigned to the Company
      as
      part of the Agreement the Company executed with Bio-One on March 22,
      2006.




On
      May 5,
      2006, the Board of Directors terminated the Nesrallahs as employees of the
      Company. On March 30, 2006, the Company filed a lawsuit in State Court in
      Orlando, Florida against the Nesrallahs, alleging, among other claims, breach
      of
      fiduciary duty to INII. As of the date of this filing, the Florida action has
      been abated pending the outcome of the results of our agreement in lieu of
      foreclosure disclosed in our Current Report on Form 8-K filed on January 12,
      2007. On March 31, 2007, management was successful in extending the letter
      of
      intent to May 4, 2007. As of the date of this filing, the agreement has expired
      in accordance with its terms. Management is attempting to obtain an extension
      of
      the expired agreement, but there can be no assurances that this will occur.
      No
      reserve has been established for a loss on this transaction, as the Company
      believes its claims are meritorious and have a reasonable probability of
      prevailing in a Court of law, or of entering into a mutually agreeable
      settlement. We have reduced our investment by $350,000 in 2006 and an additional
      $100,000 in the first quarter of 2007 for proceeds from the sale of an
      asset.  However, should the Company fail to prevail or settle its claims
      against the Seller’s, the Company will be required to write down its entire
      investment of $9,437,959 in INII. **Shareholders
      are cautioned that the loss of this investment could result in the complete
      failure of the Company and foreclosure of its remaining assets by its lender.**





The
      Company from time to time may be involved in various other lawsuits and actions
      by third parties arising in the ordinary course of business. Unless noted
      elsewhere in this filing, management is not aware of any additional pending
      litigation, claims or assessments that could have a material adverse effect
      on
      the Company’s business, financial condition and results of
      operations.





**ITEM
      2**  **.
      UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
      PROCEEDS**




None.





**ITEM
      3**  **.
      DEFAULTS UPON SENIOR SECURITIES**




None.





**ITEM
      4**  **.
      SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS**




None.





**ITEM
      5**  **.
      OTHER INFORMATION**




None.





15


**ITEM
      6. EXHIBITS AND REPORTS ON FORM 8-K**




**(A)
      Documents filed as a part of this report.**




EXHIBIT
      31.1      Officer's Certification Pursuant to Section
      302




EXHIBIT
      32.1      Certificate pursuant to 18 U.S.C. Section 1350 as
      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002




**(B)
      Current Reports filed on Form 8-K:**





Item
      7.01
      Regulation FD disclosure as filed on January 12, 2007 an incorporated herein
      by
      reference.





16


**SIGNATURES**




In
      accordance with the requirements of the Exchange Act, the Company has caused
      this Quarterly Report on Form 10-QSB/A to be signed on its behalf by the
      undersigned, thereunto duly authorized.




Date:
                September 7, 2007
            Natural
                Nutrition, Inc.
              (Formerly
                CSI Business Finance, Inc.)(Registrant)/s/
                Timothy J ConnollyTimothy
                J. Connolly
              Chief
                Executive Officer











Date:
                September 7, 2007
            Natural
                Nutrition, Inc.
              (Formerly
                CSI Business Finance, Inc.)(Registrant)/s/
                Wm Chris MathersWm
                Chris Mathers
              Chief
                Financial Officer








17